Oncology Medical News about Artificial sweeteners, cancers

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy
Cancer Epidemiology, Biomarkers & Prevention, 08/11/09

Bosetti C et al. - In a study to update the analysis of an integrated network of case-control studies conducted in Italy between 1991 and 2004 including data on cancers of the stomach, pancreas, and endometrium, the present study adds further evidence on the absence of an adverse effect of low-calorie sweetener (including aspartame) consumption on the risk of common neoplams in the Italian population.

Methods

Cases were 230 pts with incident, histologically confirmed cancers of the stomach and 547 corresponding controls, 326 of the pancreas and 652 controls, and 454 of the endometrium and 908 controls.
All controls were pts admitted to the same hospitals as cases for acute, non-neoplastic disorders.
Odds ratios (OR) and corresponding confidence intervals (CI) were derived by unconditional logistic regression models.

Results

After allowance for various confounding factors, ORs for ever users of sweeteners vs nonusers were 0.80 for gastric cancer, 0.62 for pancreatic cancer, and 0.96 for endometrial cancer.
Corresponding ORs for saccharin were 0.65, 0.19, and 0.71, and for other sweeteners were 0.86, 1.16, and 1.07, respectively, for the 3 cancer sites.

<< Previous
GSTP1-1 in ovarian cyst fluid and disease outcome of patients...

Next >>
Dermatofibrosarcoma protuberans: a tumour of nestin-positive...

Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome
Palliative Medicine, 10/05/09 Relevance Score: 63%

Screening for Cancer
MedLinePlus, 11/02/09 Relevance Score: 49%

Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09 Relevance Score: 48%

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09 Relevance Score: 48%

Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09 Relevance Score: 48%